Implantable Cardiac Monitors Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User (Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2 KEY BENEFITS

1.1.1. Secondary research

1.1.2. Primary research

1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.2.2. Top Winning Strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017*

3.2.2.2. Top Winning Strategies, By Development, 2014-2017* (%)

3.2.2.3. Top Winning Strategies, By Company, 2014-2017*

3.3. PORTERS FIVE FORCES ANALYSIS

3.4. MARKET SHARE ANALYSIS, 2016

3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Extended durability of implantable cardiac monitors

3.5.1.2. Less hospital stay and fewer hospital readmission

3.5.1.3. Rise in incidence of atrial fibrillation, myocardial infraction, and arrhythmias

3.5.2. Restraints

3.5.2.1. Availability of alternative mode of treatment

3.5.2.2. High cost of implantable cardiac monitors

3.5.3. Opportunity

3.5.3.1. Increase in awareness about devices and treatment options for cardiac disorders

CHAPTER 4 IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CARDIAC ARRHYTHMIAS

4.2.1. Key market trends and opportunities

4.2.2. Market size and forecast by region

4.2.1. Market size and forecast by country

4.3. ATRIAL FIBRILLATION

4.3.1. Key market trends and opportunities

4.3.2. Market size and forecast by region

4.3.3. Market size and forecast by country

4.4. EPILEPSY & UNEXPLAINED FALLS

4.4.1. Key market trends and opportunities

4.4.2. Market size and forecast by region

4.4.3. Market size and forecast by country

CHAPTER 5 IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast by region

5.2.2. Market size and forecast by country

5.3. CARDIAC CENTERS & CLINICS

5.3.1. Market size and forecast by region

5.3.2. Market size and forecast by country

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast by region

5.4.2. Market size and forecast by country

CHAPTER 6 IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends and opportunities

6.2.2. North America market size and forecast, by country

6.2.3. North America market size and forecast, by indication

6.2.4. North America market size and forecast, by end user

6.2.4.1. U.S., market size and forecast by Indication

6.2.4.2. U.S., market size and forecast, by end user

6.2.4.3. Canada market size and forecast, by indication

6.2.4.4. Canada market size and forecast, by end user

6.2.4.5. Mexico market size and forecast, by indication

6.2.4.6. Mexico market size and forecast, by end user

6.3. EUROPE

6.3.1. Key market trends and opportunities

6.3.2. Europe market size and forecast, by country

6.3.3. Europe market size and forecast, by indication

6.3.4. Europe market size and forecast, by end user

6.3.4.1. Germany market size and forecast, by indication

6.3.4.2. Germany market size and forecast, by end user

6.3.4.3. France market size and forecast, by indication

6.3.4.4. France market size and forecast, by end user

6.3.4.5. UK market size and forecast, by indication

6.3.4.6. UK market size and forecast, by end user

6.3.4.7. Italy market size and forecast, by indication

6.3.4.8. Italy market size and forecast, by end user

6.3.4.9. Spain market size and forecast, by indication

6.3.4.10. Spain market size and forecast, by end user

6.3.4.11. Switzerland market size and forecast, by indication

6.3.4.12. Switzerland market size and forecast, by end user

6.3.4.13. Rest of Europe market size and forecast, by indication

6.3.4.14. Rest of Europe market size and forecast, by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends and opportunities

6.4.2. Asia-Pacific market size and forecast, by country

6.4.3. Asia-Pacific market size and forecast, by indication

6.4.4. Asia-Pacific market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by indication

6.4.4.2. Japan market size and forecast, by end user

6.4.4.3. China market size and forecast, by indication

6.4.4.4. China market size and forecast, by end user

6.4.4.5. Australia market size and forecast, by indication

6.4.4.6. Australia market size and forecast, by end user

6.4.4.7. India market size and forecast, by indication

6.4.4.8. India market size and forecast, by end user

6.4.4.9. Malaysia market size and forecast, by indication

6.4.4.10. Malaysia market size and forecast, by end user

6.4.4.11. New Zealand market size and forecast, by indication

6.4.4.12. New Zealand market size and forecast, by end user

6.4.4.13. Rest of Asia-Pacific market size and forecast, by indication

6.4.4.14. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities

6.5.2. LAMEA market size and forecast, by country

6.5.3. LAMEA market size and forecast, by indication

6.5.4. LAMEA market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by indication

6.5.4.2. Brazil market size and forecast, by end user

6.5.4.3. South Africa market size and forecast, by indication

6.5.4.4. South Africa market size and forecast, by end user

6.5.4.5. Egypt market size and forecast, by indication

6.5.4.6. Egypt market size and forecast, by end user

6.5.4.7. Rest of LAMEA market size and forecast, by indication

6.5.4.8. Rest of LAMEA market size and forecast, by end user

CHAPTER 7 COMPANY PROFILE

7.1. ABBOTT LABORATORIES

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Operating business segments

7.1.4. Business performance

7.1.5. Key strategic moves and developments

7.2. BIOTRONIK SE & CO. KG

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Key strategic moves and developments

7.3. BOSTON SCIENTIFIC CORPORATION

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Business performance

7.4. EDWARDS LIFE SCIENCE CORPORATION

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Business performance

7.5. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Business performance

7.6. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.6.1. Company overview

7.6.2. Company snapshot

7.6.3. Operating business segments

7.6.4. Business performance

7.7. LIVANOVA PLC (SORIN)

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Business performance

7.8. MEDTRONIC PLC

7.8.1. Company overview

7.8.2. Company snapshot

7.8.3. Operating business segments

7.8.4. Business performance

7.8.5. Key strategic moves and developments

7.9. NIHON KOHDEN CORPORATION

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Operating business segments

7.9.4. Business performance

7.10. PHOENIX HEART PLLC

7.10.1. Company overview

7.10.2. Operating business segments

LIST OF TABLES

TABLE 1. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 2. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC ARRHYTHMIAS, BY REGION, 2016-2023 ($MILLION)

TABLE 3. IMPLANTABLE CARDIAC MONITOR MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2016-2023 ($MILLION)

TABLE 4. IMPLANTABLE CARDIAC MONITOR MARKET FOR EPILEPSY & UNEXPLAINED FALLS, BY REGION, 2016-2023 ($MILLION)

TABLE 5. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 6. IMPLANTABLE CARDIAC MONITOR MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)

TABLE 7. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC CENTERS & CLINICS, BY REGION, 2016-2023 ($MILLION)

TABLE 8. IMPLANTABLE CARDIAC MONITOR MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2016-2023 ($MILLION)

TABLE 9. IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 10. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 11. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 12. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 13. U.S. IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 14. U.S. IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 15. CANADA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 16. CANADA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 17. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 18. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 19. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 20. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 21. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 22. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 23. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 24. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 25. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 26. UK IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 27. UK IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 28. ITALY IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 29. ITALY IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 30. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 31. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 32. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 33. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 34. REST OF EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 35. REST OF EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 36. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 37. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 38. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 39. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 40. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 41. CHINA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 42. CHINA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 43. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 44. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 45. INDIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 46. INDIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 47. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 48. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 49. NEW ZEALAND IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 50. NEW ZEALAND IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 51. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 52. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 53. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 54. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 55. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 56. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 57. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 58. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 59. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 60. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 61. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 62. REST OF LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)

TABLE 63. REST OF LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 64. ABBOTT: COMPANY SNAPSHOT

TABLE 65. ABBOTT: OPERATING SEGMENTS

TABLE 66. BIOTRONIK: COMPANY SNAPSHOT

TABLE 67. BIOTRONIK: OPERATING SEGMENTS

TABLE 68. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 69. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 70. EDWARD LIFESCIENCE: COMPANY SNAPSHOT

TABLE 71. EDWARD LIFESCIENCE: OPERATING SEGMENTS

TABLE 72. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 73. GE HEALTHCARE: OPERATING SEGMENTS

TABLE 74. PHILIPS: COMPANY SNAPSHOT

TABLE 75. PHILIPS: OPERATING SEGMENTS

TABLE 76. LIVANOVA: COMPANY SNAPSHOT

TABLE 77. LIVANOVA: OPERATING SEGMENTS

TABLE 78. MEDTRONIC: COMPANY SNAPSHOT

TABLE 79. MEDTRONIC: OPERATING SEGMENTS

TABLE 80. NIHON KOHDEN: COMPANY SNAPSHOT

TABLE 81. NIHON KOHDEN: PRODUCT CATEGORIES

TABLE 82. PHOENIX HEART, PLLC:COMPANY SNAPSHOT

TABLE 83. PHOENIX HEART, PLLC: PRODUCT CATEGORIES

LIST OF FIGURES

FIGURE 1. TOTAL NUMBER OF IMPLANTABLE CARDIAC MONITOR PROCEDURES PERFORMED FROM 2016 TO 2023

FIGURE 2. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, 2016-2023

FIGURE 3. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION, 2016-2023

FIGURE 4. SEGMENTATION OF GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, 2016-2023

FIGURE 5. TOP INVESTMENT POCKETS

FIGURE 6. MODERATE BARGAINING POWER OF BUYERS

FIGURE 7. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 8. HIGH THREAT OF NEW ENTRANTS

FIGURE 9. MODERATE THREAT OF SUBSTITUTION

FIGURE 10. HIGH COMPETITIVE RIVALRY

FIGURE 11. MARKET SHARE ANALYSIS: IMPLANTABLE CARDIAC MONITOR MARKET, 2016

FIGURE 12. KEY DEVELOPMENTS FOR IMPLANTABLE CARDIAC MONITORS BY MEDTRONIC PLC

FIGURE 13. RESTRAINTS AND DRIVERS: GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET

FIGURE 14. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET: BY INDICATION

FIGURE 15. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC ARRHYTHMIAS, BY COUNTRY, 2016 VS 2023 ($MILLION)

FIGURE 16. IMPLANTABLE CARDIAC MONITOR MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2016 VS 2023 ($MILLION)

FIGURE 17. IMPLANTABLE CARDIAC MONITOR MARKET FOR EPILEPSY & UNEXPLAINED FALLS, BY COUNTRY, 2016 VS 2023 ($MILLION)

FIGURE 18. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER

FIGURE 19. IMPLANTABLE CARDIAC MONITOR MARKET FOR HOSPITALS, BY COUNTRY, 2016 VS 2023 ($MILLION)

FIGURE 20. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC CENTERS & CLINICS, BY COUNTRY, 2016 VS 2023 ($MILLION)

FIGURE 21. IMPLANTABLE CARDIAC MONITOR MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2016 VS 2023 ($MILLION)

FIGURE 22. IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION

FIGURE 23. ABBOTT: NET SALES, 2014-2016 ($MILLION)

FIGURE 24. ABBOTT: REVENUE SHARE BY SEGMENT, 2016 (%)

FIGURE 25. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

FIGURE 26. BOSTON SCIENTIFIC: NET SALES, 2014-2016 ($MILLION)

FIGURE 27. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2016 (%)

FIGURE 28. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

FIGURE 29. EDWARD LIFESCIENCE: NET SALES, 2014-2016 ($MILLION)

FIGURE 30. EDWARD LIFESCIENCE: REVENUE SHARE BY SEGMENT, 2016 (%)

FIGURE 31. EDWARD LIFESCIENCE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

FIGURE 32. GE HEALTHCARE: REVENUE, 2014-2016 ($MILLION)

FIGURE 33. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2016 (%)

FIGURE 34. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

FIGURE 35. PHILIPS: NET SALES, 2014-2016 ($MILLION)

FIGURE 36. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%)

FIGURE 37. LIVANOVA: NET SALES, 2014-2016 ($MILLION)

FIGURE 38. LIVANOVA: REVENUE SHARE BY SEGMENT, 2016 (%)

FIGURE 39. LIVANOVA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

FIGURE 40. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)

FIGURE 41. MEDTRONIC: REVENUE BY SEGMENT, 2017 (%)

FIGURE 42. MEDTRONIC: REVENUE BY GEOGRAPHY, 2017 (%)

FIGURE 43. NIHON KOHDEN: NET SALES, 2015-2017 ($MILLION)

FIGURE 44. NIHON KOHDEN: REVENUE BY PRODUCT, 2017 (%)

FIGURE 45. NIHON KOHDEN: REVENUE BY GEOGRAPHY, 2017 (%)